mesalamine
NDC 68382-435, mesalamine, tablet, delayed release, from Zydus Pharmaceuticals USA Inc..
- Product NDC
- 68382-435
- Status
- Listed
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA203286
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68382-435 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MESALAMINE800 mg/1
Pharmacologic classes
Aminosalicylate [EPC]; Aminosalicylic Acids [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68382-435-28 | 68382043528 | 180 TABLET, DELAYED RELEASE in 1 BOTTLE (68382-435-28) |
| 68382-435-77 | 68382043577 | 10 BLISTER PACK in 1 CARTON (68382-435-77) / 10 TABLET, DELAYED RELEASE in 1 BLISTER PACK (68382-435-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/ad8c7930-92e2-4372-a874-da22b9ae333eNADAC price for package 68382043528
GET /v1/drugs/nadac/68382043528
Use it
Look up 68382-435 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68382-435 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68382-435. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.